COMPASS, a Double-Blinded Randomized Phase 2/3 Study of the Efficacy and Safety of Intravenous DNL310 (Brain-Penetrant Enzyme Replacement Therapy) in MPS II
Molecular Genetics and Metabolism（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要
Molecular Genetics and Metabolism（2023）